77,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
39 °P sammeln
  • Broschiertes Buch

The use of hyperthermia in radiation oncology is well established. Many publications cover the whole field of possibilities and problems of this therapeutic modality. The new development of interstitial and intracavitary hyperthermia, however, is not well known: there are only a few relevant publications in different journals. Therefore, it was appropriate that SAUER and SEEGENSCHMIEDT organized an international meeting on this topic, where experiences with this new and promising technique were compiled and discussed by experts. The papers of this symposium together with additional review…mehr

Produktbeschreibung
The use of hyperthermia in radiation oncology is well established. Many publications cover the whole field of possibilities and problems of this therapeutic modality. The new development of interstitial and intracavitary hyperthermia, however, is not well known: there are only a few relevant publications in different journals. Therefore, it was appropriate that SAUER and SEEGENSCHMIEDT organized an international meeting on this topic, where experiences with this new and promising technique were compiled and discussed by experts. The papers of this symposium together with additional review papers and clinical studies are published in this volume. The publication begins with the physical and biological background of interstitial and intracavitary hyperthermia continues with comprehensive review papers on clinical topics and then gives examples for a wide variety of clinical applications. This volume will contribute to better understanding and application of the treatment possibilities of radio oncology in combination with this new treatment modality.
Autorenporträt
Prof. Dr. med. Rolf Sauer absolvierte eine Ausbildung in der Medizinischen Radiologie am Universitätsspital Basel bei H. Hartweg und R. Hünig. Seit 1977 Ordinarius für Strahlentherapie in Erlangen mit den Arbeits- und Forschungsschwerpunkten: organ- und funktionserhaltende Therapie bei Mammakarzinom, Harnblasenkarzinom und Analkarzinom; Radiochemotherapie von kolorektalen Karzinomen.1978 Gründung des Erlanger Tumorzentrums. 1979-1985 war er Vorsitzender der Deutschen Radioonkologen und von 1990-2000 Vorsitzender der Deutsch-Japanischen Röntgenvereinigung. Seit 1996 ist Ärztlicher Direktor des Erlanger Universitätsklinikums. Seit 2000 Vorstandsmitglied der Deutschen Gesellschaft für Senologie. Ehrenmitglied u.a. der Radiological Society of North America, Chicago.